Recent 8-K filings for MCAG

• December 15, 2025, 6:59 PM ET debt materiality 0.30 neutral item 2.03item 9.01 ◈ Debt Financings

  Mountain Crest Acquisition Corp. V enters $500K promissory note with sponsor for working capital

  Issued unsecured promissory note up to $500,000 to sponsor Mountain Crest Global Holdings LLC on December 11, 2025.

• November 7, 2025, 6:59 PM ET other material materiality 0.35 neutral item 5.03item 5.07item 8.01item 9.01 ◈ Governance Changes

  MCAG stockholders approve extension to Nov 2026; ~29K shares redeemed

  Extension to November 16, 2026 approved with 84.7% of votes cast; amendment filed with Delaware.

• August 7, 2025, 7:59 PM ET other material materiality 0.50 neutral item 4.01item 9.01 ◈ Auditor Changes ×2

  Mountain Crest Acquisition Corp. V dismisses UHY LLP and engages WWC, P.C. as auditor

  Dismissed UHY LLP on August 1, 2025, effective immediately; no disagreements or reportable events.

• April 28, 2025, 7:59 PM ET debt materiality 0.30 positive item 2.03item 9.01 ◈ Debt Financings

  Mountain Crest Acquisition Corp. V obtains $500K promissory note from sponsor for working capital

  Issued $500,000 unsecured promissory note to sponsor Mountain Crest Global Holdings LLC on April 25, 2025.

• November 19, 2024, 6:59 PM ET regulatory materiality 0.90 negative item 3.01item 9.01

  MCAG receives Nasdaq delisting notice for failing to complete business combination within 36 months

  Nasdaq notified MCAG on Nov 14, 2024 that it failed to meet IM-5101-2 by not completing a business combination within 36 months of IPO effective date (Nov 12, 2021).

• November 12, 2024, 6:59 PM ET other material materiality 0.60 neutral item 5.03item 5.07item 8.01item 9.01 ◈ Governance Changes

  MCAG extends business combination deadline to Nov 16, 2025; shareholders approve director and auditor

  Stockholders approved extension of Business Combination Period to November 16, 2025 via Amendment No. 4 to charter (75.25% of shares voted FOR).

• October 31, 2024, 7:59 PM ET regulatory materiality 0.55 positive item 3.01item 9.01

  Mountain Crest Acquisition Corp. V regains Nasdaq compliance after filing overdue Q1 and Q2 10-Qs

  Received deficiency notice on Sep 13, 2024 for late filing of Q1 and Q2 2024 10-Qs.

• September 18, 2024, 7:59 PM ET regulatory materiality 0.65 negative item 3.01item 7.01item 9.01

  Mountain Crest Receives Nasdaq Deficiency for Late Qs; Files Q1 10-Q, Submits Compliance Plan

  Received Nasdaq notice on Sept 13 for failure to timely file Q1 and Q2 10-Qs.

• September 12, 2024, 7:59 PM ET regulatory materiality 0.70 positive item 3.01

  Nasdaq confirms Mountain Crest V compliance after filing delinquent 10-K; matter closed

  Received Nasdaq notice July 18, 2024 for failure to file Form 10-K (2023) and Form 10-Q (Q1 2024).

• August 30, 2024, 7:59 PM ET M&A materiality 0.75 neutral item 1.01item 7.01item 9.01

  MCAG (SPAC) enters $375M merger with CUBEBIO, a Korean company

  Implied equity value of $375M based on $10.00 per PubCo ordinary share exchange ratio.

• August 15, 2024, 7:59 PM ET debt materiality 0.25 neutral item 2.03item 9.01

  MCAG obtains up to $500K unsecured promissory note from sponsor

  Note for up to $500K issued to sponsor Mountain Crest Global Holdings LLC on Aug 14, 2024.

• July 24, 2024, 7:59 PM ET regulatory materiality 0.60 negative item 3.01item 7.01item 9.01

  Nasdaq notifies Mountain Crest of deficiency for late 10-K and 10-Q filing

  Received Nasdaq deficiency notice on July 18, 2024, for failure to timely file Form 10-K (2023) and Form 10-Q (Q1 2024).

• June 7, 2024, 7:59 PM ET regulatory materiality 0.70 positive item 3.01

  Mountain Crest V regains Nasdaq MVLS compliance; delisting risk resolved

  Previously failed $35M market value of listed securities (MVLS) rule.

• May 2, 2024, 7:59 PM ET M&A materiality 0.80 neutral item 7.01item 9.01

  Mountain Crest V announces non-binding term sheet to combine with CUBEBIO at $620M pre-money value

  Pre-transaction equity value of CUBEBIO set at $620 million, subject to adjustment.

• May 1, 2024, 7:59 PM ET debt materiality 0.20 neutral item 2.03item 9.01 ◈ Debt Financings

  Mountain Crest Acquisition Corp. V issues $300K promissory note to sponsor for working capital

  Unsecured note of up to $300,000 issued April 30, 2024 to sponsor Mountain Crest Global Holdings LLC.

• April 24, 2024, 7:59 PM ET other material materiality 0.55 neutral item 1.01item 3.02item 9.01 ◈ Material Agreements

  Mountain Crest V converts $600K in sponsor notes into 150K shares of common stock

  Principal amount of $600,000 in promissory notes converted into 150,000 shares of common stock at $4.00/share effective April 19, 2024.

• April 3, 2024, 7:59 PM ET debt materiality 0.30 neutral item 2.03item 9.01 ◈ Debt Financings

  Mountain Crest Acquisition Corp. V enters up to $300K promissory note with sponsor for working capital

  Issued unsecured promissory note to sponsor Mountain Crest Global Holdings LLC, principal up to $300,000.

• December 19, 2023, 6:59 PM ET regulatory materiality 0.75 negative item 3.01 ◈ Listing & Compliance Notices

  Mountain Crest Acquisition Corp. V receives Nasdaq delisting notice for failing $35M MVLS requirement

  Nasdaq notified MCAG on Dec 13, 2023 that its market value of listed securities fell below $35M for 30 consecutive business days.

• November 13, 2023, 6:59 PM ET regulatory materiality 0.60 positive item 3.01

  Mountain Crest V regains Nasdaq compliance on $35M MVLS for Capital Market

  Received Nasdaq notice on Nov 9, 2023 that it met the $35M MVLS standard for continued listing on Nasdaq Capital Market.

• November 1, 2023, 7:59 PM ET debt materiality 0.40 neutral item 2.03item 9.01 ◈ Debt Financings

  Mountain Crest Acquisition Corp. V issues $400K promissory note to sponsor for working capital

  Issued $400,000 unsecured note to sponsor Mountain Crest Global Holdings LLC; no interest, due upon business combination or liquidation.

• October 26, 2023, 7:59 PM ET regulatory materiality 0.60 negative item 3.01item 9.01 ◈ Listing & Compliance Notices

  Mountain Crest Acquisition transfers to Nasdaq Capital after failing Global Market listing rules

  Received Nasdaq approval Oct 23; transfer effective Oct 27, 2023, with same tickers MCAG, MCAGU, MCAGR.

• September 19, 2023, 7:59 PM ET other material materiality 0.40 neutral item 1.01item 3.02item 9.01 ◈ Material Agreements ×2

  Mountain Crest V converts $2.1M in liabilities into 525,000 shares via vendor and note conversion agreements

  Aggregate $1.8M vendor liabilities converted into 450,000 shares at $4.00/share, extinguishing the debts.

• August 22, 2023, 7:59 PM ET other material materiality 0.65 neutral item 5.03item 5.07item 8.01item 9.01 ◈ Shareholder Votes ×6◈ Governance Changes

  Mountain Crest V shareholders approve charter changes extending deadline to Nov 2024, removing China target restriction

  Extension deadline for initial business combination moved to November 16, 2024, with $0.10/Public Share deposit per three-month extension starting Nov 17, 2023.

• July 21, 2023, 7:59 PM ET regulatory materiality 0.55 neutral item 3.01 ◈ Listing & Compliance Notices

  Nasdaq accepts MCAG's compliance plan for public float; deadline Nov 14, 2023

  On July 18, 2023, Nasdaq accepted Company's plan to regain compliance with minimum 1.1M publicly held shares requirement.

• June 30, 2023, 7:59 PM ET regulatory materiality 0.70 negative item 3.01 ◈ Listing & Compliance Notices

  MCAG receives Nasdaq delisting notice for failing MVPHS minimum of $15M

  On June 27, 2023, Nasdaq notified MCAG that its Market Value of Publicly Held Shares (MVPHS) fell below $15M for 30 consecutive business days.

• June 20, 2023, 7:59 PM ET other material materiality 0.85 negative item 1.02 ◈ Material Agreements

  Mountain Crest Acquisition Corp. V announces termination of business combination with AUM Biosciences

  AUM Biosciences delivered termination notice on June 8, 2023, ending the Business Combination Agreement.

• June 14, 2023, 7:59 PM ET other material materiality 0.85 negative item 1.02 ◈ Material Agreements

  Mountain Crest's merger with AUM Biosciences terminated by AUM on June 8, 2023

  AUM Biosciences sent termination notice on June 8, 2023, ending the Business Combination Agreement with Mountain Crest.

• May 22, 2023, 7:59 PM ET regulatory materiality 0.70 negative item 3.01 ◈ Listing & Compliance Notices

  Mountain Crest Acquisition Corp. V receives Nasdaq delisting notice for insufficient publicly held shares

  Nasdaq notice on May 18, 2023: Company fails minimum 1,100,000 publicly held shares requirement.

• May 12, 2023, 7:59 PM ET other material materiality 0.65 negative item 5.03item 5.07item 8.01item 9.01 ◈ Governance Changes◈ Shareholder Votes

  Mountain Crest V extends SPAC deadline to Feb 2024; 1.4M shares redeemed (~35%)

  Extension amendment approved by shareholders; deadline pushed from May 16, 2023 to Feb 16, 2024.

• May 11, 2023, 7:59 PM ET other material materiality 0.10 neutral item 7.01item 9.01

  Mountain Crest files corrected investor presentation for AUM Biosciences merger

  Corrected investor presentation filed to replace May 10, 2023 version.

• May 10, 2023, 7:59 PM ET other material materiality 0.25 neutral item 7.01item 9.01

  Mountain Crest V furnishes investor presentation for AUM deal; no new material info

  SPAC entered business combination agreement with AUM Biosciences on Oct 19, 2022, amended multiple times through April 19, 2023.

• April 19, 2023, 7:59 PM ET M&A materiality 0.40 neutral item 1.01item 9.01 ◈ Material Agreements ×2

  MCAG amends AUM Biosciences merger deal; reduces issued shares to 9,125,538

  Reduces issued Company Ordinary Shares from 9,841,118 to 9,125,538 as of the Amalgamation Effective Time.

• April 7, 2023, 7:59 PM ET regulatory materiality 0.75 negative item 3.01 ◈ Listing & Compliance Notices

  Mountain Crest Acquisition Corp. V receives Nasdaq delisting notice for failing $50M market value requirement

  Received Nasdaq notice on April 3, 2023 for failing $50M MVLS requirement for 30 consecutive business days.

• March 30, 2023, 7:59 PM ET M&A materiality 0.50 neutral item 1.01item 9.01

  Mountain Crest Acquisition Corp. V amends business combination agreement with AUM Biosciences

  Amendment No. 2 removes SPAC's net tangible assets closing condition and eliminates SPAC's right to designate a Holdco board director.

• February 16, 2023, 6:59 PM ET debt materiality 0.50 neutral item 2.03item 9.01 ◈ Debt Financings

  Mountain Crest Acquisition V extends business combination deadline to May 16, 2023 via $300K sponsor loan

  SPAC extended deadline to complete business combination from Feb 16, 2023 to May 16, 2023 by depositing $300,000 into trust.

• February 13, 2023, 6:59 PM ET M&A materiality 0.55 neutral item 1.01item 9.01 ◈ Material Agreements ×3

  MCAG extends business combination deadline with AUM Biosciences to May 15, 2023

  Outside Date extended from February 15, 2023 to May 15, 2023 under the Business Combination Agreement.

• January 30, 2023, 6:59 PM ET M&A materiality 0.25 neutral item 1.01item 9.01 ◈ Material Agreements

  MCAG adds newly formed entities as parties to AUM Biosciences merger agreement

  Joinder Agreement dated Jan 27, 2023 admits Holdco (AUM Biosciences Limited), Amalgamation Sub, and Merger Sub to the Oct 19, 2022 Business Combination Agreement.

• December 21, 2022, 6:59 PM ET other material materiality 0.80 neutral item 1.01item 5.03item 5.07item 8.01item 9.01 ◈ Shareholder Votes ×2◈ Governance Changes◈ Material Agreements

  MCAG stockholders approve extension to May 2023; ~4.97M shares redeemed for cash

  Stockholders approved amendment to extend business combination deadline from Feb 16, 2023 to May 16, 2023.

• December 19, 2022, 6:59 PM ET other material materiality 0.30 neutral item 5.07

  Mountain Crest Acquisition Corp. V adjourns special meeting to Dec 20 for vote on AUM Biosciences deal

  Special meeting held Dec 19, 2022, adjourned to Dec 20, 2022 at 5:00 p.m. local time.

• November 16, 2022, 6:59 PM ET M&A materiality 0.60 neutral item 7.01item 9.01

  Mountain Crest V to combine with AUM Biosciences at ~$400M valuation; PIPE of $30M sought

  Purchase price of ~$400M; AUM shareholders roll over 100% equity for ~84% of pro forma ownership.

• October 20, 2022, 7:59 PM ET M&A materiality 0.80 neutral item 1.01item 7.01item 9.01

  Mountain Crest V announces $400M business combination with AUM Biosciences

  SPAC MCAG enters Business Combination Agreement with Singapore-based AUM Biosciences; Holdco to list on Nasdaq.

• November 30, 2021, 6:59 PM ET other materiality 0.20 neutral item 8.01

  Mountain Crest V units may separate into common and rights from Dec 2

  Holders of MCAGU units may elect separate trading of common stock (MCAG) and rights (MCAGR) starting December 2, 2021.

• November 30, 2021, 6:59 PM ET other material materiality 0.10 neutral item 8.01

  Mountain Crest V announces unit separation effective Dec 2, 2021

  Holders of MCAGU units may separate into common stock (MCAG) and rights (MCAGR) starting Dec 2, 2021.

• November 24, 2021, 6:59 PM ET other material materiality 0.50 neutral item 3.02item 8.01item 9.01

  Mountain Crest Acquisition Corp. V closes over-allotment, raises additional $9M from IPO units

  Over-allotment option fully exercised: 900,000 units at $10 each, gross proceeds of $9M.

• November 22, 2021, 6:59 PM ET other material materiality 0.50 neutral item 3.02item 8.01item 9.01

  Mountain Crest V closes $60M IPO plus $9M over-allotment; $69M in trust

  IPO of 6,000,000 units at $10.00/unit raised $60M gross; over-allotment of 900,000 units raised $9M.

• November 18, 2021, 6:59 PM ET other material materiality 0.50 neutral item 1.01item 3.02item 5.03item 9.01

  Mountain Crest Acquisition Corp. V closes IPO of 6.9M units, raising $69M

  Sold 6,000,000 units at $10.00 each in IPO, plus 900,000 over-allotment units, generating aggregate gross proceeds of $69,000,000.

Materiality & sentiment trend

Max materiality 0.90 · Median 0.55 · Most common event other_material

5 positive 11 negative 30 neutral

source · MCAG on sec.gov